Market Approval for Drugs in the EU: Time to Change Direction?

European Journal of Health Economics - Germany
doi 10.1007/s10198-016-0863-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Php217 - Time to Market and Price Comparison for Biosimilar Drugs in Eu5

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

FDA Approval of New Drugs

JAMA - Journal of the American Medical Association
Medicine
2014English

FDA Approval of Obesity Drugs

JAMA - Journal of the American Medical Association
Medicine
2012English

Pricing in the Market for Anticancer Drugs

2015English

EU Supports Testing for Children's Drugs

British Medical Journal
Medicine
2005English

Time to Reimbursement for Oncology Drugs in EU5

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

EU Global Strategy: Eastern Direction

Sovremennaya Evropa
EconomicsInternational RelationsEconometricsPolitical Science
2017English

Determining Software Time-To-Market and Testing Stop Time When Release Time Is a Change-Point

International Journal of Mathematical, Engineering and Management Sciences
ManagementBusinessEngineeringComputer ScienceMathematicsAccounting
2020English

Reinvigorating the EU Single Market

OECD Economics Department Working Papers
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy